Download PDF. 1 / 3 Pages. Previous article. Go back to website. Next article. HARRIS D., Paul BRINCK M., Patricio. Un análisis retrospectivo de cavernomatosis de la vena porta en Chile: II. Hemorragia, tratamiento y pronóstico. Rev. chil. HARRIS D., Paul BRINCK M., Patricio. Un análisis retrospectivo de cavernomatosis de la vena porta en Chile.: I. Perfil clínico y de laboratorio. Rev. chil. pediatr.

Author: Mikalrajas Zololkree
Country: Gabon
Language: English (Spanish)
Genre: Relationship
Published (Last): 28 June 2006
Pages: 269
PDF File Size: 19.3 Mb
ePub File Size: 1.7 Mb
ISBN: 490-4-57157-653-5
Downloads: 59771
Price: Free* [*Free Regsitration Required]
Uploader: Dakinos

The concept of Caveronma as cavernmoa rare disease is mainly based on clinical series and case reports[ 2 ]. CT is also useful for the identification of the possible cause of the thrombosis or potential complications, such as bowel ischemia and perforation[ 22 ].

Cirrhosis Preserved liver function with precipitating factors splenectomy, surgical portosystemic shunting, TIPS dysfunction, thrombophilia Advanced disease in the absence of obvious precipitating factors. Diagnosis and management of mesenteric infarction. Anticardiolipin antibodies in patients with liver disease.

Portal hypertension-related complications after acute portal vein thrombosis: However, in the general population, its role in PVT development seems less clear, as it is considered a weak prothrombotic risk factor.

Portal vein thrombosis: Insight into physiopathology, diagnosis, and treatment

GA prothrombin gene mutation and other trombophilic polymorphisms in patients with portal or hepatic venous thrombosis. In cirrhotics with PVT, surgical procedure may be more difficult, often complicated by rethrombosis and reintervention, but portz the same morbidity and mortality of non-cirrhotic patients[,]. Clinical experience and surgical treatment in patients.

Local or systemic pro-thrombotic factors, alone or together, can play an important role in PVT pathogenesis, which is complex and different in each clinical context and in each patient.


There was a problem providing the content you requested

Etiology and consequences of thrombosis in abdominal vessels. Portal hypertension due to portal venous thrombosis: Portal vein thrombosis PVT is a relatively common complication in patients with liver cirrhosis, but might also occur in absence of an overt liver disease.

Furthermore, prota and, consequently, pancytopenia, are commonly present in chronic PVT[ 1 ]; however, if one branch of the portal vein is preserved and the portal pressure is quite normal, they may even be absent. Eur J Gastroenterol Hepatol. In cirrhotics with PVT, the risk of variceal bleeding is nearly times higher than in patients without liver disease, although the outcome seems better[ 6566 ].

Recently, several studies tried to identify the strongest predictive factors for PVT development in these patients.

The occlusion of the portal vein is always more scarring than the cavenoma of the hepatic artery and may be seriously threatening for both graft and patient survival[ ]. MR, CT, and ultrasonography of splanchnic venous thrombosis. Portal vein thrombosis after variceal endoscopic sclerotherapy in cirrhotic patients: Among the other thrombophilic disorders, a prothrombin gene mutation seems to be frequent among cirrhotics with PVT[ 231 – 34 ].

Despite the activation of this complex system of support, the impairment of portal flow has important consequences on liver tissue. N Engl J Med. Improved results of liver transplantation in patients with portal vein thrombosis.

In PVT patients, liver function is typically conserved. Recanalization cavernomq paraumbilical vein CT scan ; E: Extrahepatic portal vein thrombosis: They are more frequent after an episode of gastrointestinal bleeding or associated with renal failure or sepsis in older patients[ 86467 ]. Anticoagulation in chronic PVT Opinions regarding therapeutic options in chronic PVT are more controversial and significantly variable. The spectrum of portal vein thrombosis in liver transplantation.


Portal vein thrombosis: Insight into physiopathology, diagnosis, and treatment

Vascular disorders of the liver. However, the limit of EUS is the presence of a relatively blind area, which cannot be investigated, involving the distal superior mesenteric vein and the intrahepatic portion of the portal vein[ 76 ].

Table 3 Prevalence of thrombotic risk factors in series of routinely investigated, consecutive adult patients with non tumorous and non cirrhotic, acute or chronic, PVT[ ]. Furthermore, contrast-enhanced MR angiography is useful to assess flow direction in the portal venous system and its patency, to identify a cavernomatous transformation, to determine the presence of varices, and to verify the correct function of surgical shunts[ 8182 ]. PVT is considered a milestone in the natural history of liver cirrhosis and it is related to serious complications, morbidity, and cavwrnoma, as previously discussed[ 87 ].

MR imaging of complications after liver transplantation. Cholestasis as presenting vna of portal cavernoma.

Open in a separate window. Value of CT and sonography in the conservative management of acute splenoportal and superior mesenteric venous thrombosis. Portal vein thrombosis in cirrhotics: Role of the JAK2 mutation in the diagnosis of chronic myeloproliferative disorders in splanchnic vein thrombosis. MRI might also cqvernoma the vascular occlusion; at spin-echo MR, the clot appears isointense on T1- weighted images, or hyperintense if recent, and usually cavetnoma a more intense signal on T2 images.

Am J Med Sci. The incidence among cirrhotic patients is still unknown, but recent data suggest a prevalence of about 0.